UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia

BMC psychiatry, 2011-09, Vol.11 (1), p.152-152, Article 152

2011

Volltextzugriff (PDF)

Updating and Confirming an Industry-Sponsored Pharmacoeconomic Model: Comparing Two Antipsychotics in the Treatment of Schizophrenia

Value in health, 2012-01, Vol.15 (1), p.55-64

2012

Volltextzugriff (PDF)

Treatment response trajectories and antipsychotic medications: Examination of up to 18 months of treatment in the CATIE chronic schizophrenia trial

Schizophrenia research, 2012-05, Vol.137 (1), p.141-146

2012

Volltextzugriff (PDF)

Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States

Cost effectiveness and resource allocation, 2009-04, Vol.7 (4), p.4-4, Article 4

2009

Volltextzugriff (PDF)

Extent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: Evidence from the CATIE study

Schizophrenia research, 2011-12, Vol.133 (1), p.42-46

2011

Volltextzugriff (PDF)

Cost-effectiveness of olanzapine long-acting injection in the treatment of patients with schizophrenia in the United States: a micro-simulation economic decision model

Current medical research and opinion, 2011-04, Vol.27 (4), p.713-730

2011

Volltextzugriff (PDF)

Computer Mediated Communication and Student Learning in Large Introductory Sociology Classes

Teaching Sociology, 2005-04, Vol.33 (2), p.122-135

2005

Volltextzugriff (PDF)

Comparing symptom response among antipsychotic medications in CATIE

Journal of clinical psychopharmacology, 2013-02, Vol.33 (1), p.123-126

2013

Volltextzugriff (PDF)

Comparing Symptom Response Among Antipsychotic Medications in CATIE

Journal of clinical psychopharmacology, 2012-12, p.1

2012

Volltextzugriff (PDF)

Poster #189 COMPARING SYMPTOM RESPONSE AMONG ANTIPSYCHOTIC MEDICATIONS IN CATIE

Schizophrenia research, 2012-04, Vol.136, p.S253-S254

2012

Volltextzugriff (PDF)

Poster #219 DIFFERENCES BETWEEN PATIENTS UNDERGOING AUGMENTATION OR SWITCHING OF ANTIPSYCHOTIC MEDICATIONS DURING TREATMENT OF SCHIZOPHRENIA

Schizophrenia research, 2012-04, Vol.136, p.S169-S169

2012

Volltextzugriff (PDF)

Cost-effectiveness of several atypical antipsychotics in orally disintegrating tablets compared with standard oral tablets in the treatment of schizophrenia in the United States

Journal of medical economics, 2012, Vol.15 (3), p.531-547

2012

Volltextzugriff (PDF)

VALIDATING AN INDUSTRY-SPONSORED MODEL COMPARING THE COST-EFFECTIVENESS OF ATYPICAL ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA

Schizophrenia research, 2010-04, Vol.117 (2), p.398-399

2010

Volltextzugriff (PDF)

Overestimating the prevalence of subtherapeutic dosing of atypical antipsychotics

The journal of clinical psychiatry, 2009-08, Vol.70 (8), p.1189-1190

2009

Volltextzugriff (PDF)

Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia

Neuropsychiatric disease and treatment, 2012-01, Vol.8 (default), p.113-118

2012

Volltextzugriff (PDF)

Treatment response trajectories and antipsychotic medications: Examination of up to 18months of treatment in the CATIE chronic schizophrenia trial

Schizophrenia research, 2012-05, Vol.137 (1-3), p.141-146

2012

Volltextzugriff (PDF)

HIV Prevention Services for Adults with Serious Mental Illness in Public Mental Health Care Programs

Journal of prevention & intervention in the community, 2007-02, Vol.33 (1-2), p.63-77

2007

Volltextzugriff (PDF)

Extent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: Evidence from the CATIE sturdy

Schizophrenia research, 2011, Vol.133 (1-3), p.42-46

2011

Volltextzugriff (PDF)

Phenotypic variation in photosynthetic traits in wheat grown under field versus glasshouse conditions

Journal of experimental botany, 2022-05, Vol.73 (10), p.3221-3237

2022

Volltextzugriff (PDF)

Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients

BMC cancer, 2018-02, Vol.18 (1), p.130-130, Article 130

2018

Volltextzugriff (PDF)

Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial

JAMA : the journal of the American Medical Association, 2014-06, Vol.311 (23), p.2397

2014

Volltextzugriff (PDF)

Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma

Clinical cancer research, 2015-01, Vol.21 (1), p.175-183

2015

Volltextzugriff (PDF)

HLA-C06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis

Journal of allergy and clinical immunology, 2019-06, Vol.143 (6), p.2120-2130

2019

Volltextzugriff (PDF)

Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies

The Journal of molecular diagnostics : JMD, 2016-03, Vol.18 (2), p.299-315

2016

Volltextzugriff (PDF)

Hypoxia shapes the immune landscape in lung injury and promotes the persistence of inflammation

Nature immunology, 2022-06, Vol.23 (6), p.927-939

2022

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(110)

Publikationsform

Sprache

Englisch
(138)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia

Updating and Confirming an Industry-Sponsored Pharmacoeconomic Model: Comparing Two Antipsychotics in the Treatment of Schizophrenia

Treatment response trajectories and antipsychotic medications: Examination of up to 18 months of treatment in the CATIE chronic schizophrenia trial

Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States

Extent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: Evidence from the CATIE study

Cost-effectiveness of olanzapine long-acting injection in the treatment of patients with schizophrenia in the United States: a micro-simulation economic decision model

Computer Mediated Communication and Student Learning in Large Introductory Sociology Classes

Comparing symptom response among antipsychotic medications in CATIE

Comparing Symptom Response Among Antipsychotic Medications in CATIE

Poster #189 COMPARING SYMPTOM RESPONSE AMONG ANTIPSYCHOTIC MEDICATIONS IN CATIE

Poster #219 DIFFERENCES BETWEEN PATIENTS UNDERGOING AUGMENTATION OR SWITCHING OF ANTIPSYCHOTIC MEDICATIONS DURING TREATMENT OF SCHIZOPHRENIA

Cost-effectiveness of several atypical antipsychotics in orally disintegrating tablets compared with standard oral tablets in the treatment of schizophrenia in the United States

VALIDATING AN INDUSTRY-SPONSORED MODEL COMPARING THE COST-EFFECTIVENESS OF ATYPICAL ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA

Overestimating the prevalence of subtherapeutic dosing of atypical antipsychotics

Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia

Treatment response trajectories and antipsychotic medications: Examination of up to 18months of treatment in the CATIE chronic schizophrenia trial

HIV Prevention Services for Adults with Serious Mental Illness in Public Mental Health Care Programs

Extent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: Evidence from the CATIE sturdy

Phenotypic variation in photosynthetic traits in wheat grown under field versus glasshouse conditions

Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients

Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial

Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma

HLA-C06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis

Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies

Hypoxia shapes the immune landscape in lung injury and promotes the persistence of inflammation

Suchergebnisse filtern